Solvay Pharma

• SOLVAY PHARMA INDIA LTD. - Record Date for Scheme of Amalgamation

  Abbott India Ltd has informed BSE that it has fixed August 29, 2011 as the Record Date for the purpose of determining the entitlement of shareholders of Solvay Pharma India Ltd, who will be allotted shares of Abbott India Ltd, in terms of the Share Swap Ratio of 2:3.

• SOLVAY PHARMA INDIA LTD. - Updates on Scheme of Amalgamation

  Solvay Pharma India Ltd has informed BSE that the Order passed by the Hon'ble High Court of Bombay sanctioning the Scheme of Amalgamation of Solvay Pharma India Ltd. with Abbott India Ltd. has been filed with the Registrar of Companies, Maharashtra, on August 10, 2011.

• Solvay Pharma India Ltd - Updates on Resignation of Managing Director

  With reference to the earlier announcement dated March 29, 2011, regarding Mr. Niteen Gadgil had tendered his resignation as Managing Director of the Company and that he would, continue for some time to ensure that the process of merger is carried out smoothly, Solvay Pharma India Ltd has now informed BSE that Mr. Gadgil will be relieved of his res...

• Solvay Pharma India net profit rises 46.05% in the March 2010 quarter

  Sales rise 24.57% to Rs 62.25 croreNet profit of Solvay Pharma India rose 46.05% to Rs 11.29 crore in the quarter ended March 2010 as against Rs 7.73 crore during the previous quarter ended March 2009. Sales rose 24.57% to Rs 62.25 crore in the quarter ended March 2010 as against Rs 49.97 crore during the previous quarter ended March 2009. Particul...

• Solvay Pharma India net profit rises 52.77% in the December 2009 quarter

  Sales rise 19.83% to Rs 66.10 croreNet profit of Solvay Pharma India rose 52.77% to Rs 10.48 crore in the quarter ended December 2009 as against Rs 6.86 crore during the previous quarter ended December 2008. Sales rose 19.83% to Rs 66.10 crore in the quarter ended December 2009 as against Rs 55.16 crore during the previous quarter ended December 20...

• Solvay Pharma India recommends final dividend

  Of 200%The board of Solvay Pharma India in its meeting on 25 January 2010 has recommended final dividend at the rate of Rs. 20 per share (200%) for the year 2009.

• Solvay Pharma India net profit rises 15.50% in the September 2009 quarter

  Sales rise 16.07% to Rs 63.36 croreNet profit of Solvay Pharma India rose 15.50% to Rs 11.25 crore in the quarter ended September 2009 as against Rs 9.74 crore during the previous quarter ended September 2008. Sales rose 16.07% to Rs 63.36 crore in the quarter ended September 2009 as against Rs 54.59 crore during the previous quarter ended Septembe...

• Solvay Pharma India net profit rises 15.50% in the September 2009 quarter

  Sales rise 16.07% to Rs 63.36 croreNet profit of Solvay Pharma India rose 15.50% to Rs 11.25 crore in the quarter ended September 2009 as against Rs 9.74 crore during the previous quarter ended September 2008. Sales rose 16.07% to Rs 63.36 crore in the quarter ended September 2009 as against Rs 54.59 crore during the previous quarter ended Septembe...

• Solvay Pharma soars after takeover at the parent firm level

  Solvay Pharma India spurted 14.27% to Rs 935 at 10:21 IST after American healthcare major Abbott Laboratories on Monday, 28 September 2009, said it will buy pharma business of Solvay's Belgium-based parent for US$ 6.6 billion.Meanwhile, the BSE Sensex was up 196.09 points, or 1.17%, to 16889.09. On BSE, 3955 shares were traded in the counter as aga...

• Solvay Pharma India Ltd - Publish Audited Results

  Solvay Pharma India Ltd has informed BSE that the Company shall publish the audited results within 60 days from the end of the last quarter and as such the unaudited results for the last quarter ended December 31, 2010 will not be published within 45 days from the quarter ended December 31, 2010.

• Solvay Pharma India Ltd - Outcome of Board Meeting

  Solvay Pharma India Ltd has informed BSE that the Boards of Directors of Abbott India Ltd. ("Abbott India") and Solvay Pharma India Ltd. ("Solvay Pharma India"), at their meetings held on November 24, 2010, have unanimously approved the draft scheme for the amalgamation of Solvay Pharma India into Abbott India under sections 391 to ...

• Solvay Pharma India Ltd - Board Meeting on Nov 24, 2010

  Solvay Pharma India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 24, 2010, to consider the merger of the company with Abbott India Limited, the valuation of shares and share exchange ratio, fairness opinion, draft Auditor's certificate and the scheme of merger.

• Solvay Pharma India Ltd - Change in Directorate

  Solvay Pharma India Ltd has informed BSE that :  1. Mr. Olivier Du Roy has resigned as alternate Director to Roger Kearns w.e.f. August 02, 2010 and  2. Mr. Roger Kearns has resigned as a Director of the Company w.e.f. August 03, 2010.

• Solvay Pharma India Ltd - Payment Date for Dividend

  The board at its meeting held on October 29, 2011 has approved for the same

• Solvay Pharma India Ltd - Resignation of Managing Director

  The board at its meeting held on October 29, 2011 has approved for the same